Zinc is an essential micronutrient that supports innate and adaptive immunity, mucosal repair, and cytokine regulation. Evidence shows that zinc supplementation during acute infections is most clearly beneficial for specific groups rather than universally for all patients. Clinical guidance and trials identify who gains the greatest, evidence-backed advantage.
Who benefits most
Children under five in low- and middle-income countries experience the clearest, highest-impact benefits. The World Health Organization recommends zinc treatment alongside oral rehydration for acute childhood diarrhea, reflecting reductions in duration and subsequent diarrheal episodes. Zulfiqar A. Bhutta Aga Khan University has published extensively on micronutrient interventions and child survival, supporting zinc’s role where baseline deficiency and high diarrheal burden coexist. Adults and older people with documented zinc deficiency—for example due to malabsorption, chronic liver disease, or inadequate dietary intake—also benefit from targeted supplementation during infections because deficiency impairs immune responses.
Other clinically supported contexts
Acute upper respiratory infections have mixed evidence, but meta-analyses by Harri Hemilä University of Helsinki suggest that zinc salts delivered as lozenges and started within 24 hours of symptom onset can shorten the common cold in otherwise healthy adults. Effectiveness depends on formulation, dose, and timing. Routine zinc use for all respiratory infections is not universally endorsed; benefit concentrates where early, appropriate dosing is applied or where deficiency is present.
Mechanisms explaining who benefits include increased zinc loss during diarrheal illness, greater baseline deficiency in populations with limited animal-source foods or poor soil zinc affecting crops, and age-related changes in absorption. Consequences of targeted supplementation are largely positive: shortened illness, fewer complications, and reduced healthcare visits in high-risk groups. However, indiscriminate high-dose zinc carries risks such as gastrointestinal upset and interference with copper absorption, leading to potential long-term hematologic or neurologic consequences if not monitored.
Clinical decision-making should combine assessment of nutritional status, local epidemiology, and available formulations. Public health programs in resource-limited settings yield the largest population health gains by integrating zinc supplementation into diarrhea management protocols. In wealthier settings, clinicians should reserve supplementation for documented deficiency or specific early-treatment regimens supported by trial evidence.